Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT02308904
Eligibility Criteria:
Inclusion Criteria:
* Transfusion-dependent\* females and males with thalassemia (any genotype) who are 12 to 45 years of age.
* History of at least 5 years of chronic transfusion (defined as ≥ 8 transfusions/year) (Age of initiation of transfusions does not matter)
* Any pubertal stage.
* Liver iron evaluated by SQUID, MRI or liver biopsy within 12 months prior to enrollment in the study.
* Need to be able to stop hormonal therapy for 3 weeks (males) and one month (females) prior to study enrollment.
Exclusion Criteria:
* Pregnant or lactating during study enrollment
* Unable to obtain liver iron concentration within 12 months prior or 6 months after study entry.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT02308904
Study Brief:
Protocol Section:
NCT02308904